Frequency of Subtypes of Biliary Intraductal Papillary Mucinous Neoplasm and Their MUC1, MUC2, and DPC4 Expression Patterns Differ from Pancreatic Intraductal Papillary Mucinous Neoplasm

被引:25
作者
Sclabas, Guido M. [1 ]
Barton, Joshua G. [1 ]
Smyrk, Thomas C. [2 ]
Barrett, David A. [2 ]
Khan, Saboor [1 ]
Kendrick, Michael L. [1 ]
Reid-Lombardo, Kaye M. [1 ]
Donohue, John H. [1 ]
Nagorney, David M. [1 ]
Que, Florencia G. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Gen Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Div Anat Pathol, Rochester, MN 55905 USA
关键词
BILE-DUCT; INTRAEPITHELIAL NEOPLASIA; PATHOLOGICAL FEATURES; CARCINOMA; TRACT; ADENOCARCINOMA; CLASSIFICATION; LESIONS; GENE; IPMN;
D O I
10.1016/j.jamcollsurg.2011.09.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Biliary intraductal papillary mucinous neoplasm (B-IPMN) has been proposed as a unique clinicopathologic disease with distinct histopathologic features, although wide acceptance remains controversial. A recent consensus conference classified pancreatic IPMN (P-IPMN) into 4 subtypes (ie, gastric, intestinal, pancreatobiliary, oncocytic) based on morphologic appearance and mucin (MUC) staining properties. The aim of this study was to determine whether B-IPMN has similar histopathologic and immunologic subtypes to P-IPMN. STUDY DESIGN: Specific immunostaining for MUC1, MUC2, and deleted for pancreas cancer, locus 4 were performed on specimens from 19 patients with a histopathologic diagnosis of B-IPMN. Immunostaining patterns of B-IPMN were correlated with histopathology. RESULTS: Based on histopathology, the following subtypes of B-IPMN were identified: pancreatobiliary n = 9 (47%), intestinal n = 8 (42%), oncocytic n = 2 (11%), and gastric n = 0 (0%). Pancreatobiliary and oncocytic subtypes of B-IPMN were positive for MUC1 and negative for MUC2, and intestinal subtypes were positive for MUC2 and negative for MUC1. Thirteen of the 19 B-IPMN were associated with invasive carcinoma; loss of deleted for pancreas cancer, locus 4 was found in 6 of 13 invasive components and in 3 of 19 noninvasive components of B-IPMN. Five-year survival for patients with resected B-IPMN and invasive carcinoma was 38%, which is similar to that for resected P-IPMN with invasive carcinoma. CONCLUSIONS: Histopathologic subtypes and type-specific MUC expression patterns of B-IPMN resemble those of P-IPMN. MUC1 expression and/or absence of MUC2 expression, which correlate with aggressive features of P-IPMN, were found in B-IPMN and correlate with invasive B-IPMN. Loss of deleted for pancreas cancer, locus 4 parallels the findings observed in P-IPMN. These findings provide additional support that B-IPMN is a unique entity with similarities to main duct P-IPMN. (J Am Coll Surg 2012; 214: 27-32. (C) 2012 by the American College of Surgeons)
引用
收藏
页码:27 / 32
页数:6
相关论文
共 35 条
[1]   The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis [J].
Adsay, NV ;
Merati, K ;
Andea, A ;
Sarkar, F ;
Hruban, RH ;
Wilentz, RE ;
Goggins, M ;
Iocobuzio-Donahue, C ;
Longnecker, DS ;
Klimstra, DS .
MODERN PATHOLOGY, 2002, 15 (10) :1087-1095
[2]  
Argani P, 2001, CANCER, V91, P1332
[3]   Smads as transcriptional co-modulators [J].
Attisano, L ;
Wrana, JL .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :235-243
[4]   The Smads [J].
Liliana Attisano ;
Si Tuen Lee-Hoeflich .
Genome Biology, 2 (8)
[5]   Intraductal Papillary Mucinous Neoplasm: A Clinicopathologic Review [J].
Augustin, Toms ;
VanderMeer, Thomas J. .
SURGICAL CLINICS OF NORTH AMERICA, 2010, 90 (02) :377-+
[6]   Intracluctal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathologic difference between 2 major types [J].
Ban, Shinichi ;
Naitoh, Yoshihisa ;
Mino-Kenudson, Mari ;
Sakurai, Takaki ;
Kuroda, Makoto ;
Koyama, Isamu ;
Lauwers, Gregory Y. ;
Shimizu, Michio .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (12) :1561-1569
[7]   Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? [J].
Barton, Joshua G. ;
Barrett, David A. ;
Maricevich, Marco A. ;
Schnelldorfer, Thomas ;
Wood, Christina M. ;
Smyrk, Thomas C. ;
Baron, Todd H. ;
Sarr, Michael G. ;
Donohue, John H. ;
Farnell, Michael B. ;
Kendrick, Michael L. ;
Nagorney, David M. ;
Lombardo, Kaye M. Reid ;
Que, Florencia G. .
HPB, 2009, 11 (08) :684-691
[8]   Natural history of intraductal papillary mucinous neoplasms (IPMN): Current evidence and implications for management [J].
Bassi, Claudio ;
Sarr, Michael G. ;
Lillemoe, Keith D. ;
Reber, Howard A. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (04) :645-650
[9]   Adenocarcinoma of the distal bile duct - A clinicopathologic outcome analysis after curative resection [J].
Bortolasi, L ;
Burgart, LJ ;
Tsiotos, GG ;
Luque-de Leon, E ;
Sarr, MG .
DIGESTIVE SURGERY, 2000, 17 (01) :36-41
[10]   Immunohistochemical study of DPC4 and P53 proteins in gallbladder and bile duct cancers [J].
Chuang, SC ;
Lee, KT ;
Tsai, KB ;
Sheen, PC ;
Nagai, E ;
Mizumoto, K ;
Tanaka, M .
WORLD JOURNAL OF SURGERY, 2004, 28 (10) :995-1000